Status:
COMPLETED
HoLEP Vs BPEP for Large Prostatic Adenoma
Lead Sponsor:
Ahmed Maher Gamil Ahmed Higazy
Conditions:
Prostate Hyperplasia
Eligibility:
MALE
Phase:
PHASE3
Brief Summary
Benign prostatic hyperplasia (BPH) is one of the most common urinary disorders in elderly males. The symptoms of BPH include impaired physiological and functional well-being, which interferes with dai...
Detailed Description
Enlarged prostate represents the most common cause of lower urinary tract symptoms (LUTS) in elderly men including irritative, obstructive urinary symptoms or even urinary retention that significantly...
Eligibility Criteria
Inclusion
- Men who are fit for surgery and need a surgical resection of the prostate larger than 80 ml including:
- Bothersome LUTS with an IPSS score over 19
- Refractory hematuria
- Upper urinary tract affection
- Recurrent UTI secondary to prostatic enlargement
- Maximum uroflow rate (Qmax) below 10 ml/sec.
- bladder diverticula
- Urinary retention whether recurrent acute attacks with failure of medical treatment or chronic retention.
Exclusion
- Patients with:
- Neurogenic bladder
- Previous prostate or urethral surgery
- Associated urethral stricture
- Prostate cancer diagnosed by TRUS biopsy
- Bladder stones,
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04275076
Start Date
February 1 2018
End Date
February 1 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Hospitals
Cairo, Egypt, 11361